← Back
$NUVB All transactions

Nuvation Bio Inc.

A

$ Value

$0

Shares

224,439

Price

$0

Filed

Mar 3

Insider

Name

Makunje Moses

Title

SEE REMARKS

CIK

0002001938

Roles

Officer

Transaction Details

Transaction Date

2026-02-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

224,439

Footnotes

Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date. | Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan. | Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Filing Info

Accession No.

0002001938-26-000004

Form Type

4

Issuer CIK

0001811063

Makunje Moses's History

Date Ticker Type Value
2026-02-27 NUVB A $0
2026-02-27 NUVB A $0

Other Insiders at NUVB (90d)

Insider Bought Sold Last
Hung David
PRESIDENT AND CEO
2026-02-27
Wentworth Kerry
CHIEF REGULATORY OFFICER
$1.1M 2026-04-17
Cui Xiangmin 2026-02-27
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
2026-02-27
Markel Stacy
CHIEF PEOPLE OFFICER
2026-02-27
Hanley David C.
CHIEF TECHNICAL OPERATIONS
2026-02-27
Liu Dongfang
CHIEF MEDICAL OFFICER
$251K 2026-04-17
Makunje Moses
SEE REMARKS
2026-02-27
Sjogren Colleen
Chief Commercial Officer
2026-02-27
Sauvage Philippe
Chief Financial Officer
2026-02-27